evaluation of the therapeutic effect of hemorrhidoplasty laser in hemorrhides

A Comparative Study between the Therapeutic Results of Laser Hemorrhoidoplasty and Milligan-Morgan’s Open Surgical Hemorrhoidectomy in Patients with Hemorrhoids

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200909048672N2

Enrollment

100

Registered

2023-01-03

Start date

2022-09-23

Completion date

Unknown

Last updated

2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anal Hemorrhoid Grade III. Condition 2: Anal Hemorrhoid Grade IV. Third degree hemorrhoids Fourth degree hemorrhoids

Interventions

Intervention 1: Control group: Hemorrhoidectomy in Milligan Morgan procedure. Intervention 2: Intervention group: Laser Hemorrhoidoplasty. To perform the procedure in the intervention group, a 23 mm P

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: aged > 18 years grade III, IV hemorrhoids non-respondent to medical treatment willing to participate in the study

Exclusion criteria

Exclusion criteria: patients with Fissure patients with Fistula patients with Coagulation disorder substance abuse Irritable bowel disease patients who had hemorrhoid surgery treatment earlier

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: Before intervention and 1st, 4th and 12th weeks after intervention. Method of measurement: Visual Analogue Scale questionnaire.;Itching. Timepoint: Before intervention and 1st, 4th and 12th weeks after intervention. Method of measurement: asking the questions from patients.;Bleeding. Timepoint: Before intervention and 1st, 4th and 12th weeks after intervention. Method of measurement: asking the questions from patients.;Complications. Timepoint: 1st, 4th and 12th weeks after intervention. Method of measurement: Visit by attending physician and asking the questions from patients.	—

Measure

Time frame

Pain. Timepoint: Before intervention and 1st, 4th and 12th weeks after intervention. Method of measurement: Visual Analogue Scale questionnaire.;Itching. Timepoint: Before intervention and 1st, 4th and 12th weeks after intervention. Method of measurement: asking the questions from patients.;Bleeding. Timepoint: Before intervention and 1st, 4th and 12th weeks after intervention. Method of measurement: asking the questions from patients.;Complications. Timepoint: 1st, 4th and 12th weeks after intervention. Method of measurement: Visit by attending physician and asking the questions from patients.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Eshraghi

Esfahan University of Medical Sciences

eshraghireza@med.mui.ac.ir+98 913 300 2036

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026